Overview

Apatinib as Maintenance Therapy After First Line Treatment in Locally Advanced or Metastatic Gastric Cancer

Status:
Unknown status
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
The study is to evaluate the efficacy of Apatinib in patients with advanced or metastatic adenocarcinoma of stomach or gastroesophageal junction.
Phase:
Phase 3
Details
Lead Sponsor:
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Treatments:
Apatinib